Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Cobenfy Approval Brings 20% Upside To Bristol Myers Squibb Stock
This is a big approval for the company, given that Cobenfy doesn’t have the classic side effects seen in other antipsychotic drugs.
Bristol-Myers Squibb Likely To Revalue Higher Following New Drug Approval
Bristol-Myers Squibb's stock is set to rise with FDA approvals, acquisitions, and a strong oncology portfolio, despite potential risks. Read more on BMY here.
U.S. Regulator Approves Bristol Myers Squibb’s (NYSE:BMY) Schizophrenia Drug
Shares of pharmaceutical company Bristol Myers Squibb ($BMY) are up 4% on news that the U.S. Food and Drug Administration (FDA) has approved its
The Gazette
19h
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
(Reuters) -
Bristol
Myers
Squibb
won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former ...
3d
Bristol-Myers Squibb: Sell Rating Justified by Market Challenges and Drug Uptake Concerns
Terence Flynn, an analyst from Morgan Stanley, maintained the Sell rating on Bristol-Myers Squibb (BMY – Research Report). The associated ...
Business Wire
2d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
NBA Hall of Famer dies
‘Ring of fire’ eclipse in Oct
Helene wreaks havoc
Trump's Erie rally
Illegal cloning sentencing
Blocks songs from artists
Grammy-winning singer dies
NYC tunnel shutdown
Harris' Las Vegas rally
To receive FEMA briefing
Mich. nuclear plant to restart
Line Fire prompts evacuation
Oil prices climb
US port strike looms
Firefighters injured in crash
Newsom vetoes AI safety bill
Defensive Player of the Year
37 militants killed in Syria
Crew-9 astronauts at ISS
Israeli forces launch raids
Sells stake in DirecTV
To sue Google, Samsung
US wins Presidents Cup
Three PFLP leaders killed
$567M Taiwan defense aid
Seeks bribery dismissal
Ozzie Virgil Sr. dies at 92
Nepal floods: Death toll rises
Feedback